Founded To Serve Healthservier Is A Global Group Governed By A Foundation That Aspires To Have A Meaningful Social Impactboth For Patients And For A Sustainable Worldwith Its Unique Governance Modelit Can Fully Serve Its Vocation With A Long Term Visionbeing Committed To Therapeutic Progress To Serve Patient Needsthe 21 400 Employees Of The Group Are Committed To This Shared Vocationsource Of Inspiration Every Day As A World Leader In Cardiologyservier S Ambition Is To Become A Renownedfocused And Innovative Player In Oncology By Targeting Hard To Treat Cancersthat Is Why The Group Allocates Over 50Of Its R&D Budget To Developing Targeted And Innovative Therapies In Oncology Neuroscience And Immuno Inflammatory Diseases Are The Future Growth Driversin These Areasservier Is Focused On A Limited Number Of Diseases In Which Accurate Patient Profiling Makes It Possible To Offer A Targeted Therapeutic Response Through Precision Medicine To Promote Access To Quality Care For All At A Lower Costthe Group Also Offers A Range Of Quality Generic Drugs Covering Most Pathologiesrelying On Strong Brands In Franceeastern Europebrazil And Nigeria In All These Areasthe Group Includes The Patient Voice At Each Stage Of The Life Cycle Of A Medicine Headquartered In Franceservier Relies On A Strong Geographical Footprint In Over 150 Countries And Achieved A Revenue Of A 4 9 Billion In 2022 Servier Indonesia Was Established In 1987 Under Pt Parvico Bersaudara And Legally Founded As Pt Servier Indonesia In 2005We Are Focusing On 4 Therapeutic Areascardiovascularhypertensionmetabolic And Chronic Venous Diseasefurther Informationplease Visit Www Servier Co Idto Report A Suspected Adverse Event With A Servier Drugplease Visit Www Servier Co Id
